Antioxidative effects of cerium dioxide nanoparticles ameliorate age-related male infertility: Optimistic results in rats and the review of clinical clues for integrative concept of men health and fertility

EPMA Journal

Volumn 6, Issue 1, 2015, Pages

  Kobyliak, Nazarii M ^a   Falalyeyeva, Tetyana M ^b   Kuryk, Olena G ^c   Beregova, Tetyana V ^b   Bodnar, Petro M ^a   Zholobak, Nadiya M ^d   Shcherbakov, Oleksandr B ^d   Bubnov, Rostyslav V ^d,f   Spivak, Ya M ^d,e  

^a BOGOMOLETS NATIONAL MEDICAL UNIVERSITY   (Ukraine)

^b TARAS SHEVCHENKO NATIONAL UNIVERSITY OF KYIV   (Ukraine)

^c Scientific and Practical Centre of Preventive and Clinical Medicine   (Ukraine)

^d ZABOLOTNY INSTITUTE OF MICROBIOLOGY AND VIROLOGY   (Ukraine)

^e LCL Diaprof   (Ukraine)

^f Clinical Hospital 'Pheophania' of State Affairs Department   (Ukraine)

Author keywords

Age related male infertility; Infertility biomarkers; Men health; Nanocrystalline cerium dioxide; Oxidative antioxidative balance; Predictive, preventive, and personalized medicine; Seminal plasma; Translation; Ultrasound

Indexed keywords

CATALASE; CERIUM OXIDE; CITRIC ACID; NANOPARTICLE; SUPEROXIDE DISMUTASE; TESTOSTERONE;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ATROPHY; CELL ACTIVATION; CELL COUNT; CELL VIABILITY; CONTROLLED STUDY; DRUG COATING; DRUG EFFECT; ECHOGRAPHY; ENZYME ACTIVITY; EPIDIDYMIS; LEYDIG CELL; LIPID PEROXIDATION; MALE; MALE FERTILITY; MALE GENITAL SYSTEM; MALE GENITAL TRACT PARAMETERS; MALE INFERTILITY; MEN'S HEALTH; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; SEMINIFEROUS TUBULE; SPERMATOGENESIS; SPERMATOZOON COUNT; SPERMATOZOON MOTILITY; SPERMATOZOON PERCENTAGE; TESTIS SIZE; TESTOSTERONE BLOOD LEVEL; TISSUE REGENERATION;

EID: 84935013516     PISSN: 18785077     EISSN: 18785085     Source Type: Journal    
DOI: 10.1186/s13167-015-0034-2     Document Type: Article

References (142)

1. Shcherbakov AB, Zholobak NM, Ivanov VK, Tret'yakov YD, Spivak NY. Nanomaterials based on the nanocrystalline ceria: properties and use perspectives in biology and medicine. Biotechnologia Acta. 2011;4(1):9-28.
2. Shcherbakov AB, Ivanov VK, Zholobak NM, Ivanova OS, Krysanov EI, Baranchikov AE. Nanocrystaline ceria based materials-perspectives for biomedical application. Biofizika. 2011;56(6):995-1015.
3. Nolan M, Parker SC, Watson GW. Reduction of NO2 on ceria surfaces. J Phys Chem B. 2006;110(5):2256-62.
4. Hochella Jr MF, Lower SK, Maurice PA, Penn RL, Sahai N, Sparks DL, et al. Nanominerals, mineral nanoparticles, and earth systems. Science. 2008;319(5870):1631-5.
5. Naganuma T, Traversa E. Stability of the Ce3+ valence state in cerium oxide nanoparticle layers. Nanoscale. 2012;4(16):4950-3.
6. Deshpande S, Patil S, Kuchibhatla SV, Seal S. Size dependency variation in lattice parameter and valency states in nanocrystalline cerium oxide. Appl Phys Lett. 2005;87:133113.
7. Celardo I, Traversa E, Ghibelli L. Cerium oxide nanoparticles: a promise for applications in therapy. J Exp Ther Oncol. 2011;9(1):47-51.
8. Das S, Dowding JM, Klump KE, McGinnis JF, Self W, Seal S. Cerium oxide nanoparticles: applications and prospects in nanomedicine. Nanomedicine (Lond). 2013;8(9):1483-508.
9. Celardo I, Pedersen JZ, Traversa E, Ghibelli L. Pharmacological potential of cerium oxide nanoparticles. Nanoscale. 2011;3(4):1411-20.
10. Korsvik C, Patil S, Seal S, Self WT. Superoxide dismutase mimetic properties exhibited by vacancy engineered ceria nanoparticles. Chem Commun. 2007;10:1056-8.
11. Heckert EG, Karakoti AS, Seal S, Self WT. The role of cerium redox state in the SOD mimetic activity of nanoceria. Biomaterials. 2008;29(18):2705-9.
12. Pirmohamed T, Dowding JM, Singh S, Wasserman B, Heckert E, Karakoti AS, et al. Nanoceria exhibit redox state-dependent catalase mimetic activity. Chem Commun. 2010;46(16):2736-8.
13. Xue Y, Luan Q, Yang D, Yao X, Zhou K. Direct evidence for hydroxyl radical scavenging activity of cerium oxide nanoparticles. J Phys Chem C. 2011;115(11):4433-8.
14. Dowding JM, Dosani T, Kumar A, Seal S, Self WT. Cerium oxide nanoparticles scavenge nitric oxide radical (NO). Chem Commun. 2012;48(40):4896-8.
15. Colon J, Herrera L, Smith J, Patil S, Komanski C, Kupelian P, et al. Protection from radiation-induced pneumonitis using cerium oxide nanoparticles. Nanomedicine. 2009;5(2):225-31.
16. Hirst SM, Karakoti A, Singh S, Self W, Tyler R, Seal S, et al. Bio-distribution and in vivo antioxidant effects of cerium oxide nanoparticles in mice. Environ Toxicol. 2013;28(2):107-18.
17. Lombardo F, Sansone A, Romanelli F, Paoli D, Gandini L, Lenzi A. The role of antioxidant therapy in the treatment of male infertility: an overview. Asian J Androl. 2011;13(5):690-7.
18. Griveau JF, Le Lannou D. Reactive oxygen species and human spermatozoa: physiology and pathology. Int J Androl. 1997;20:61-9.
19. Agarwal A, Saleh RA, Bedaiwy MA. Role of reactive oxygen species in the pathophysiology of human reproduction. Fertil Steril. 2003;79(4):829-43.
20. Ray PD, Huang BW, Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal. 2012;24(5):981-90.
21. Lopes S, Jurisicova A, Sun JG, Casper RF. Reactive oxygen species: potential cause for DNA fragmentation in human spermatozoa. Hum Reprod. 1998;13(4):896-900.
22. Aitken RJ, De Iuliis GN, Finnie JM, Hedges A, McLachlan RI. Analysis of the relationships between oxidative stress, DNA damage and sperm vitality in a patient population: development of diagnostic criteria. Hum Reprod. 2010;10(25):2415-26.
23. Baumber J, Ball BA, Gravance CG, Medina V, Davies-Morel MC. The effect of reactive oxygen species on equine sperm motility, viability, acrosomal integrity, mitochondrial membrane potential, and membrane lipid peroxidation. J Androl. 2000;21(6):895-902.
24. Kao SH, Chao HT, Chen HW, Hwang TI, Liao TL, Wei YH. Increase in oxidative stress in human sperm with lower motility. Fertil Steril. 2008;89(5):1183-90.
25. Jin J, Jin N, Zheng H, Ro S, Tafolla D, Sanders KM, et al. Catsper3 and Catsper4 are essential for sperm hyperactivated motility and male fertility in the mouse. Biol Reprod. 2007;77(1):37-44.
26. Jervis KM, Robaire B. The effects of long-term vitamin E treatment on gene expression and oxidative stress damage in the aging brown Norway rat epididymis. Biol Reprod. 2004;71(4):1088-95.
27. Nosenko ND, Zholobak NM, Poliakova LI, Sinitsyn PV, Lymarieva AA, Shcherbakov OV, et al. Morphofunctional state of reproductive system of ageing male rats in case of using nanocerium. Fiziol Zh. 2014;60(1):11-7.
28. Ivanov VK, Polezhaeva OS, Shaporev AS, Baranchikov AE, Shcherbakov AB, Usatenko AV. Synthesis and thermal stability of nanocrystalline ceria sols stabilized by citric and polyacrylic acid. Russ J Inorg Chem. 2010;55(3):328-32.
29. World Health Organization. WHO laboratory manual for the examination and processing of human semen. 5th ed. Geneva, Switzerland: World Health Organization; 2010.
30. Johnsen SG. Testicular biopsy score count-a method for registration of spermatogenesis in human testes: normal values and results in 335 hypogonadal males. Hormones. 1970;1(1):2-25.
31. Gavrilov VB, Gavrilova AR, Khmara NF. Measurement of diene conjugates in blood plasma using the UV absorption of heptane and isopropanol extracts. Laboratornoe Delo. 1988;2:60-4.
32. Timirbulatov RA, Seleznev EI. Method for increasing the intensity of free radical oxidation of lipid-containing components of the blood and its diagnostic significance. Laboratornoe Delo. 1981;4:209-11.
33. Kolesova OE, Markin AA, Fedorova TN. Lipid peroxidation and methods of determining its products in biological media. Laboratornoe Delo. 1984;4:540-6.
34. Chevari S, Chaba I, Sekei I. Role of superoxide dismutase in cellular oxidative processes and method of its determination in biological materials. Laboratornoe Delo. 1985;11:678-81.
35. Koroliuk MA, Ivanova LI, Maiorova IG, Tokarev VE. A method of determining catalase activity. Laboratornoe Delo. 1988;1:16-9.
36. Asati A, Santra S, Kaittanis C, Nath S, Perez JM. Oxidase-like activity of polymer-coated cerium oxide nanoparticles. Angew Chem Int Ed Engl. 2009;48(13):2308-12.
37. Asati A, Santra S, Kaittanis C, Perez JM. Surface-charge-dependent cell localization and cytotoxicity of cerium oxide nanoparticles. ACS Nano. 2010;4(9):5321-31.
38. Wason MS, Zhao J. Cerium oxide nanoparticles: potential applications for cancer and other diseases. Am J Transl Res. 2013;5(2):126-31.
39. Wason MS, Colon J, Das S, Seal S, Turkson J, Zhao J, et al. Sensitization of pancreatic cancer cells to radiation by cerium oxide nanoparticle-induced ROS production. Nanomedicine. 2013;9(4):558-69.
40. Alili L, Sack M, Karakoti AS, Teuber S, Puschmann K, Hirst SM, et al. Combined cytotoxic and anti-invasive properties of redoxactive nanoparticles in tumor-stroma interactions. Biomaterials. 2011;32(11):2918-29.
41. Karakoti AS, Munusamy P, Hostetler K, Kodali V, Kuchibhatla S, Orr G, et al. Preparation and characterization challenges to understanding environmental and biological impacts of ceria nanoparticles. Surf Interface Anal. 2012;44(8):882-9.
42. Levy S, Robaire B. Segment-specific changes with age in the expression of junctional proteins and the permeability of the blood/epididymis barrier in rats. Biol Reprod. 1999;60(6):1392-401.
43. Rzigalinski BA, Meehan K, Davis RM, Xu Y, Miles WC, Cohen CA. Radical nanomedicine. Nanomedicine (Lond) 2006. 2006;1(4):399-412.
44. Aziz N, Saleh RA, Sharma RK, Lewis-Jones I, Esfandiari N, Thomas Jr AJ, et al. Novel association between sperm reactive oxygen species production, sperm morphological defects, and the sperm deformity index. Fertil Steril. 2004;81(2):349-54.
45. De Lamirande E, Gagnon C. Reactive oxygen species and human spermatozoa: physiology and pathology. Int J Androl. 1992;13(5):368-78.
46. Yoshida Y, Itoh N, Saito Y, Hayakawa M, Niki E. Application of water soluble radical initiator, 2, 2-azobis[2, (2-1 midazolin-2-yi) propane] dihydrochloride to a study of oxidative stress. Free Radic Res. 2004;38(4):375-84.
47. Agarwal A, Prabakaran S, Allamaneni S. What an andrologist/urologist should know about free radicals and why. Urology. 2006;67(1):2-8.
48. Paniagua R, Nistal M, Saez FJ, Fraile B. Ultrastructure of the aging human testis. J Electron Microsc Tech. 1991;19(2):241-60.
49. Vom Saul FS, Finch CE. Reproductive senescence; phenomena and mechanisms in mammals and selected vertebrates. In: Knobil E, Neill J, editors. The Physiology of Reproduction, vol. 2. New York: Raven Press; 1988. p. 2351-413.
50. Clegg ED, Perreault D, Klinefelter GR. Assessment of male reproductive toxicity. In: Hayes AW, editor. Principles and Methods of Toxicology. Philadelphia: Taylor and Francis; 2001. p. 1263-300.
51. Tourinho PS, Waalewijn-Kool PL, Zantkuijl I, Jurkschat K, Svendsen C, Soares AM, et al. CeO2 nanoparticles induce no changes in phenanthrene toxicity to the soil organisms Porcellionides pruinosus and Folsomia candida. Ecotoxicol Environ Saf. 2015;113:201-6.
52. Lahive E, Jurkschat K, Shaw BJ, Handy RD, Spurgeon DJ, Svendsen C. Toxicity of cerium oxide nanoparticles to the earthworm Eisenia fetida: subtle effects. Environ Chem. 2014;11(3):268-78.
53. Colon J, Hsieh N, Ferguson A, Kupelian P, Seal S, Jenkins DW, et al. Cerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2. Nanomedicine. 2010;6(5):698-705.
54. Yefimenko OY, Savchenko YO, Falalyeyeva TM, Beregova TV, Zholobak NM, Spivak MY, et al. Nanocrystalline cerium dioxide efficacy for gastrointestinal motility: potential for prokinetic treatment and prevention in elderly. EPMA J. 2015;6:6.
55. Limbach LK, Bereiter R, Müller E, Krebs R, Gälli R, Stark WJ. Removal of oxide nanoparticles in a model wastewater treatment plant: influence of agglomeration and surfactants on clearing efficiency. Environ Sci Technol. 2008;42(15):5828-33.
56. Collin B, Auffan M, Johnson AC, Kaur I, Keller AA, Lazareva A, et al. Environmental release, fate and ecotoxicological effects of manufactured ceria nanomaterials. Environ Sci: Nano. 2014;1(6):533-48.
57. Sajid M, Ilyas M, Basheer C, Tariq M, Daud M, Baig N, et al. Impact of nanoparticles on human and environment: review of toxicity factors, exposures, control strategies, and future prospects. Environ Sci Pollut Res. 2014;1-22.
58. Golubnitschaja O, Costigliola V. EPMA: General report & recommendations in predictive, preventive and personalised medicine 2012: white paper of the European Association for Predictive, Preventive and Personalised medicine. EPMA J. 2012;3:14.
59. Harris ID, Fronczak C, Roth L, Meacham RB. Fertility and the aging male. Rev Urol. 2011;13(4):e184-90.
60. Stephen EH, Chandra A. Updated projections of infertility in the United States: 1995-2025. Fertil Steril. 1998;70:30-4.
61. Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Kirmeyer S. Births: final data for 2006. Natl Vital Stat Rep. 2009;57:1-101.
62. Martin JA, Hamilton BE, Osterman MJ, Curtin SC, Matthews TJ. Births: final data for 2013. Natl Vital Stat Rep. 2015;64(1):1-68.
63. Lampic C, Svanberg AS, Karlström P, Tydén T. Fertility awareness, intentions concerning childbearing, and attitudes towards parenthood among female and male academics. Hum Reprod. 2005;21:558-64.
64. Slama R, Bouyer J, Windham G, Fenster L, Werwatz A, Swan SH. Influence of paternal age on the risk of spontaneous abortion. Am J Epidemiol. 2005;161(9):816-23.
65. Sartorius GA, Nieschlag E. Paternal age and reproduction. Hum Reprod Update. 2010;16(1):65-79.
66. Ford WC, North K, Taylor H, Farrow A, Hull MG, Golding J. Increasing paternal age is associated with delayed conception in a large population of fertile couples: evidence for declining fecundity in older men. The ALSPAC study team (Avon longitudinal study of pregnancy and childhood). Hum Reprod. 2000;15:1703-8.
67. Rosen RC, Wing R, Schneider S, Gendrano 3rd N. Epidemiology of erectile dysfunction: the role of medical comorbidities and lifestyle factors. Urol Clin North Am. 2005;32(4):403-17.
68. Drabovich AP, Jarvi K, Diamandis EP. Verification of male infertility biomarkers in seminal plasma by multiplex selected reaction monitoring assay. Mol Cell Proteomics. 2011;10(12):M110.004127. doi: 10.1074/mcp.M110.004127.
69. Drabovich AP, Saraon P, Jarvi K, Diamandis EP. Seminal plasma as a diagnostic fluid for male reproductive system disorders. Nat Rev Urol. 2014;11(5):278-88.
70. Sloter E, Schmid TE, Marchetti F, Eskenazi B, Nath J, Wyrobek AJ. Quantitative effects of male age on sperm motion. Hum Reprod. 2006;21(11):2868-75.
71. Wald M, Makhlouf AA, Niederberger CS. Therapeutic testis biopsy for sperm retrieval. Curr Opin Urol. 2007;17(6):431-8.
72. Rolland AD, Lavigne R, Dauly C, Calvel P, Kervarrec C, Freour T, et al. Identification of genital tract markers in the human seminal plasma using an integrative genomics approach. Hum Reprod. 2013;28(1):199-209.
73. Yamakawa K, Yoshida K, Nishikawa H, Kato T, Iwamoto T. Comparative analysis of interindividual variations in the seminal plasma proteome of fertile men with identification of potential markers for azoospermia in infertile patients. J Androl. 2007;28:858-65.
74. Yap TA, Swanton C, de Bono JS. Personalization of prostate cancer prevention and therapy: are clinically qualified biomarkers in the horizon? EPMA J. 2012;3:3.
75. Ferlin A, Raicu F, Gatta V, Zuccarello D, Palka G, Foresta C. Male infertility: role of genetic background. Reprod Biomed Online. 2007;14(6):734-45.
76. Vogt PH. Molecular genetic of human male infertility: from genes to new therapeutic perspectives. Curr Pharm Des. 2004;10(5):471-500.
77. Elzanaty S. Association between age and epididymal and accessory sex gland function and their relation to sperm motility. Arch Androl. 2007;53:149-56.
78. Krapfenbauer K, Drucker E, Thurnher D. Identification of tumour-related proteins as potential screening markers by proteome analysis-protein profiles of human saliva as a predictive and prognostic tool. EPMA J. 2014;5:20.
79. Dalle-Donne I, Scaloni A, Giustarini D, Cavarra E, Tell G, Lungarella G, et al. Proteins as biomarkers of oxidative/nitrosative stress in diseases: the contribution of redox proteomics. Mass Spectrom Rev. 2005;24(1):55-99.
80. Ogino K, Wang DH. Biomarkers of oxidative/nitrosative stress: an approach to disease prevention. Acta Med Okayama. 2007;61(4):181-9.
81. Zholobak NM, Sherbakov AB, Babenko LS, Bogorad-Kobelska OS, Bubnov RV, Spivak MY, et al. The perspectives of biomedical application of the nanoceria. EPMA J. 2014;5 Suppl 1:A136.
82. Zorn B, Golob B, Ihan A, Kopitar A, Kolbezen M. Apoptotic sperm biomarkers and their correlation with conventional sperm parameters and male fertility potential. J Assist Reprod Genet. 2012;29(4):357-64. doi: 10.1007/s10815-012-9718-x.
83. Ward TH, Cummings J, Dean E, Greystoke A, Hou JM, Backen A, et al. Biomarkers of apoptosis. Br J Cancer. 2008;99:841-6.
84. Purvis K, Christiansen E. Infection in the male reproductive tract. Impact, diagnosis and treatment in relation to male infertility. Int J Androl. 1993;16(1):1-13.
85. Johnson L, Petty CS, Porter JC, Neaves WB. Germ cell degeneration during postprophase of meiosis and serum concentrations of gonadotropins in young adult and older adult men. Biol Reprod. 1984;31:779-84.
86. Schurich M, Aigner F, Frauscher F, Pallwein L. The role of ultrasound in assessment of male fertility. Eur J Obstet Gynecol Reprod Biol. 2009;144 Suppl 1:S192-8. doi: 10.1016/j.ejogrb.2009.02.034.
87. Sánchez Guerrero A, Villor Esnal R, Pamplona Casamayor M. Radiological diagnosis: scrotal ultrasound and Doppler ultrasound in the diagnosis of male infertility. Arch Esp Urol. 2004;57(9):905-20.
88. Kühnert B, Nieschlag E. Reproductive functions of the ageing male. Hum Reprod Update. 2004;10:327-39.
89. Mahmoud AM, Goemaere S, El-Garem Y, et al. Testicular volume in relation to hormonal indices of gonadal function in community dwelling elderly men. J Clin Endocrinol Metab. 2003;88:179-84.
90. Sakamoto H, Yajima T, Nagata M, Okumura T, Suzuki K, Ogawa Y. Relationship between testicular size by ultrasound and testicular function: measurement of testicular length, width, and depth in patients with infertility. Int J Urol. 2008;15:529-33.
91. Mbaeri TU, Orakwe JC, Nwofor AME, Oranusi CK, Mbonu OO. Ultrasound measurements of testicular volume: comparing the three common formulas with the true testicular volume determined by water displacement. Afr J Urol. 2013;19:69-73.
92. Ganem JP, Workman KR, Shaban SF. Testicular microlithiasis is associated with testicular pathology. Urology. 1999;53(1):209-13.
93. Sakamoto H, Saito K, Shichizyo T, Ishikawa K, Igarashi A, Yoshida H. Color Doppler ultrasonography as a routine clinical examination in male infertility. Int J Urol. 2006;13(8):1073-8.
94. Sasano N, Ichijo S. Vascular patterns of the human testis with special reference to its senile changes. Tohoku J Exp Med. 1969;99:269-80.
95. Mukhomor AI, Bubnov RV. Using modern radiological methods for prostate cancer diagnostics. Lik Sprava. 2010;5-6:118-23.
96. Marmar JL, Benoff S. The safety of ultrasonically guided testis aspiration biopsies and efficacy of use to predict varicocelectomy outcome. Hum Reprod. 2005;20(8):2279-88.
97. Sjögren F, Anderson CD. Are cutaneous microdialysis cytokine findings supported by end point biopsy immunohistochemistry findings? AAPS J. 2010;12(4):741-9. doi: 10.1208/s12248-010-9235-8.
98. Fisher JS. Environmental anti-androgens and male reproductive health: focus on phthalates and testicular dysgenesis syndrome. Reproduction. 2004;127(3):305-15.
99. Benoff S, Hurley IR, Barcia M, Mandel FS, Cooper GW, Hershlag A. A potential role for cadmium in the etiology of varicocele-associated infertility. Fertil Steril. 1997;67:336-47.
100. Mahboubi M, Foroughi F, Ghahramani F, Shahandeh H, Moradi S, Shirzadian T. A case-control study of the factors affecting male infertility. Turk J Med Sci. 2014;44(5):862-5.
101. Hargreave TB, Elton RA, Webb JA, Busuttil A, Chisholm GD. Maldescended testes and fertility: a review of 68 cases. Br J Urol. 1984;56(6):734-9.
102. Chavez-Badiola A, Drakeley AJ, Finney V, Sajjad Y, Lewis-Jones DI. Necrospermia, antisperm antibodies, and vasectomy. Fertil Steril. 2008;89(3):723. e5-7.
103. Bubnov RV. Evidence-based pain management: is the concept of integrative medicine applicable? EPMA J. 2012;3(1):13.
104. Konieczka K, Ritch R, Traverso CE, Kim DM, Kook MS, Gallino A, et al. Flammer syndrome. EPMA J. 2014;5:11.
105. Mohr BA, Guay AT, O'Donnell AB, McKinlay JB. Normal, bound and nonbound testosterone levels in normally ageing men: results from the Massachusetts Male Ageing Study. Clin Endocrinol (Oxf). 2005;62(1):64-73.
106. Sheweita SA, Tilmisany AM, Al-Sawaf H. Mechanisms of male infertility: role of antioxidants. Curr Drug Metab. 2005;6(5):495-501.
107. Kasturi SS, Tannir J, Brannigan RE. The metabolic syndrome and male infertility. J Androl. 2008;29(3):251-9.
108. Morrison CD, Brannigan RE. Metabolic syndrome and infertility in men. Best Pract Res Clin Obstet Gynaecol. 2015;29(4):507-15.
109. La Vignera S, Calogero AE, Condorelli R, Lanzafame F, Giammusso B, Vicari E. Andrological characterization of the patient with diabetes mellitus. Minerva Endocrinol. 2009;34(1):1-9.
110. Bener A, Al-Ansari AA, Zirie M, Al-Hamaq AO. Is male fertility associated with type 2 diabetes mellitus? Int Urol Nephrol. 2009;41(4):777-84.
111. Agbaje IM, Rogers DA, McVicar CM, McClure N, Atkinson AB, Mallidis C, et al. Insulin dependant diabetes mellitus: implications for male reproductive function. Hum Reprod. 2007;22(7):1871-7.
112. O'Donovan PA, Vandekerckhove P, Lilford RJ, Hughes E. Infertility: Treatment of male infertility: is it effective? Review and meta-analyses of published randomized controlled trials. Hum Reprod. 1993;8(8):1209-22.
113. Agarwal A, Saleh RA. Role of oxidants in male infertility: rationale, significance, and treatment. Urol Clin North Am. 2002;29(4):817-27.
114. Agarwal A, Nallella KP, Allamaneni SS, Said TM. Role of antioxidants in treatment of male infertility: an overview of the literature. Reprod Biomed Online. 2004;8(6):616-27.
115. Tremellen K. Oxidative stress and male infertility-a clinical perspective. Hum Reprod Update. 2008;14(3):243-58.
116. Trovato GM. Behavior, nutrition and lifestyle in a comprehensive health and disease paradigm: skills and knowledge for a predictive, preventive and personalized medicine. EPMA J. 2012;3(1):8.
117. Savcheniuk OA, Virchenko OV, Falalyeyeva TM, Beregova Tetyana V, Babenko LP, Lazarenko LM, et al. The efficacy of probiotics for monosodium glutamate-induced obesity: dietology concerns and opportunities for prevention. EPMA J. 2014;5(1):2.
118. Horváth M, Czeizel E. Effect of a new dietary supplement on sperm quality. Orv Hetil. 2012;153(45):1787-92.
119. Grygoruk C, Mrugacz G, Ratomski K, Grusza M, Kanczuga-Koda L, Pietrewicz P. Influence of the anti-inflammatory, anti-bacterial and anti-oxidative treatment combined with the dietary supplementation on sperm parameters. Pol Merkur Lekarski. 2012;33(198):322-4.
120. Nosseir NS, Ali MM, Ebaid HM. A histological and morphometric study of monosodium glutamate toxic effect on testicular structure and potentiality of recovery in adult albino rat. Res J Biol. 2012;2(2):66-78.
121. Cederroth CR, Zimmermann C, Nef S. Soy, phytoestrogens and their impact on reproductive health. Mol Cell Endocrinol. 2012;355(2):192-200. doi: 10.1016/j.mce.2011.05.049.
122. Vilela ML, Willingham E, Buckley J, Liu BC, Agras K, Shiroyanagi Y, et al. Endocrine disruptors and hypospadias: role of genistein and the fungicide vinclozolin. Urology. 2007;70(3):618-21.
123. Chia SE, Lim ST, Tay SK, Lim ST. Factors associated with male infertility: a case-control study of 218 infertile and 240 fertile men. BJOG. 2000;107(1):55-61.
124. Lucía A, Chicharro JL, Pérez M, Serratosa L, Bandrés F, Legido JC. Reproductive function in male endurance athletes: sperm analysis and hormonal profile. J Appl Physiol (1985). 1996;81(6):2627-36.
125. Arce JC, De Souza MJ. Exercise and male factor infertility. Sports Med. 1993;15(3):146-69.
126. Solomon S, Cappa KG. Impotence and bicycling. A seldom-reported connection. Postgrad Med. 1987;81(1):99-100. 102.
127. Gulino G, Sasso F, D'Onofrio A, Palermo G, Di Luigi F, Sacco E, et al. Sport, infertility and erectile dysfunction. Urologia. 2009;77(2):100-6.
128. Safarinejad MR, Azma K, Kolahi AA. The effects of intensive, long-term treadmill running on reproductive hormones, hypothalamus-pituitary-testis axis, and semen quality: a randomized controlled study. J Endocrinol. 2009;200(3):259-71.
129. Baste V, Riise T, Moen BE. Radiofrequency electromagnetic fields; male infertility and sex ratio of offspring. Eur J Epidemiol. 2008;23(5):369-77.
130. Møllerløkken OJ, Moen BE. Is fertility reduced among men exposed to radiofrequency fields in the Norwegian Navy? Bioelectromagnetics. 2008;29(5):345-52.
131. Agarwal A, Desai NR, Makker K, Varghese A, Mouradi R, Sabanegh E, et al. Effects of radiofrequency electromagnetic waves (RF-EMW) from cellular phones on human ejaculated semen: an in vitro pilot study. Fertil Steril. 2009;92(4):1318-25.
132. Rosen RC, Catania J, Pollack L, Althof S, O'Leary M, Seftel AD. Male sexual health questionnaire (MSHQ): scale development and psychometric validation. Urology. 2004;64(4):777-82.
133. [ http://www.maleinfertility.org/Schlegel-questionnaire.pdf ] Accessed 11 April 2015.
134. Blander DS, Sanchez-Ortiz RF, Broderick GA. Sex inventories: can questionnaires replace erectile dysfunction testing? Urology. 1999;54:719-23.
135. Tang Z, Li D, Zhang X, Yi L, Zhu X, Zeng X, et al. Comparison of the simplified International Index of Erectile Function (IIEF-5) in patients of erectile dysfunction with different pathophysiologies. BMC Urol. 2014;14:52. doi: 10.1186/1471-2490-14-52.
136. Eisenberg ML, Hsieh MH, Walters RC, Krasnow R, Lipshultz LI. The Relationship between anogenital distance, fatherhood, and fertility in adult men. PLoS ONE. 2011;6(5):e18973. doi: 10.1371/journal.pone.0018973.
137. Afriansyah A, Gani YI, Nusali H. Comparison between visual prostate symptom score and international prostate symptom score in males older than 40 years in rural Indonesia. Prostate Int. 2014;2(4):176-81.
138. Goncharenko VM, Beniuk VA, Kalenska OV, Demchenko OM, Spivak MY, Bubnov RV. Predictive diagnosis of endometrial hyperplasia and personalized therapeutic strategy in women of fertile age. EPMA J. 2013;4:24.
139. Shapira N. Women's higher health risks in the obesogenic environment: a gender nutrition approach to metabolic dimorphism with predictive, preventive, and personalised medicine. EPMA J. 2013;4(1):1.
140. Golubnitschaja O, Costigliola V. EPMA: EPMA summit 2014 under the auspices of the presidency of Italy in the EU: professional statements. EPMA J. 2015;6:4.
141. Grech G, Zhan X, Yoo BC, Bubnov R, Hagan S, Danesi R, et al. EPMA position paper in cancer: current overview and future perspectives. EPMA J. 2015;6:9.
142. Nolte J, Engel W. Artificial Sperm. J Reproduktionsmed Endokrinol. 2013;10(Special Issue):66-71.